Attendee Registration - 6:30 am to 5:00 pm
EXHIBITS OPEN 11:30 Am to 4:30 pm

Thursday, September 12, 2019


Plenary Session


Scheduled Time

Welcome to IMW17 Organizers of IMW17 8:00 AM
History of IMW RA Kyle 8:30 AM
IMS President Address: State of the Art for Myeloma in 2019 J San Miguel  8:45 AM
Precursor Conditions    9:00 AM
Session Chairs RA Kyle / F Davies  
Risk factors for MGUS/SMM progression V Rajkumar  9:00 AM
Genomic Profiling: How is MGUS/SM different from Active MM? N Bolli  9:15 AM
Role of the Microenvironment in MGUS progression M Dhodapkar  9:30 AM
MGRS and other Paraprotein Related Conditions JP Fermand  9:45 AM
Management of Smoldering Myeloma MV Mateos  10:00 AM
New Concepts in Preventing SM Progression I Ghobrial  10:15 AM
Multiple Myeloma: Diagnosis and Management    
Session Chairs M Boccadoro/V Rajkumar  10:30 AM
Diagnostic Criteria and Workup in 2019 S Kumar  10:30 AM
How do we use prognostic factors to Guide Treatment Decisions? P Sonneveld  10:45 AM
When and how should MRD be evaluated in MM? B Paiva  11:00 AM
Should MRD status guide drug development and approval? F Gay  11:15 AM
Challenges with current MM response criteria J Blade  11:30 AM
Imaging Approaches for MM E Zamagni  11:45 AM

12:00 PM to 1:00 pm - Lunch and EXHIBITS OPEN

Multiple Myeloma Genomics    1:00 PM
Session Chairs R Fonseca/WJ Chng  
Somatic Variants in Newly Diagnosed MM H Avet-Loiseau  1:00 PM
Clonal Diversity and Evolution in Myeloma N Munshi  1:10 PM
Transcriptome of Malignant Plasma Cells G Morgan  1:20 PM
Epigenomics of Myeloma C Ott  1:30 PM
Signalomics of Malignant Plasma Cells M Rabb   1:40 PM
Importance of Microbiome in MM Growth and Survival L Bergsagel  1:50 PM
Panel Discussion   2:00 PM
Multiple Myeloma: Current Treatment Approaches    2:30 PM
Session Chairs P Richardson/MV Mateos  
Treatment of Newly Diagnosed Myeloma Transplant Eligible M Cavo  2:30 PM
Treatment of Newly Diagnosed Myeloma Non-Transplant T Facon  2:40 PM
Consolidation Strategies for MM E Staudtmauer  2:50 PM
Maintenance Strategies for MM P McCarthy  3:00 PM
Treatment Options for Relapsed/Refractory Patients P Moreau  3:10 PM
Treatment Options for Later Relapse and Refractory Patients S Lonial  3:20 PM
Panel Discussion   3:30 PM

4:00 pm - Afternoon Break and EXHIBITS OPEN

Hot Topics in Myeloma    4:30 PM
In 2019, is ASCT the right answer for all transplant eligible MM patients?    
Session Moderators M Cavo/S Zweegman  4:30 PM
Panelists - M Mohty/H Goldschmidt/D Siegel/M Attal M Mohty/H Goldschmidt/D Siegel/F Gay  4:45 PM
In 2019, when is allogeneic transplant the right answer for MM ?    
Session Moderators S Giralt/H Einsele  5:00 PM
Panelists - J Wolfe/G Gahrton/W Bensinger/TBD J Wolf/G Gahrton/W Bensinger/A Krishan  5:15 PM
Keynote Addresses    5:30 PM
What are the critical unanswered questions for MM in 2019? M Dimopoulos  5:30 PM
Castleman’s Disease: A Personal Journey DC Fajgenbaum  5:45 PM
Day Adjournment   6:00 PM

Opening Ceremonies and Young Investigator Award
Presentations at the Boston Museum of Science - 7:30 PM


Workshop Organizers

Christopher Patterson
IMW 17 Secretariat

Dana Farber Cancer Institute
Mayor 548
450 Brookline Avenue
Boston, MA 02215
+1 617 632 6285


Follow the IMS

icon facebook icon twitter

Become a Member Today

Housing & Registration


c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
+ 1 703-449-6418 (International)

Reserve Now

Contact the IMS

International Myeloma Society

Lisa Sikkink, IMS Assistant

International Myeloma Society
Mayo Clinic
Siebens 6-60
200 First Street SW
Rochester, MN 55905
+1 507 284 3725